Genome-Based Diagnostics: Demonstrating Clinical Utility in Oncology
Publisher: National Academies Press 2013
Number of pages: 100
Genome-Based Diagnostics assesses the evidentiary requirements for clinical utility of molecular diagnostics used to guide treatment decisions for patients with cancer; discusses methodologies related to demonstrating these evidentiary requirements that meet the needs of all stakeholders; and considers innovative, sustainable research collaborations for generating evidence of clinical utility involving multiple stakeholders.
Home page url
Download or read it online for free here:
- International Agency for Research on Cancer
This volume Evaluates the carcinogenic risk to humans posed by infection with three schistosoma trematodes, three liver flukes and Helicobacter pylori, selected on the basis of a causal association between infection and the development of cancers.
- World Health Organization
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies, and highlights the need for collaboration across programmes, organizations and partners.
by Joanna Parish (ed.) - MDPI AG
In this volume, we seek to explore novel mechanisms of cellular transformation by oncogenic viruses, the role of viral infection in cancer development in understudied body sites and the potential role of novel viral pathogens in cancer development.
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.